LLY vs WMT: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Walmart Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Eli Lilly and Company · Healthcare
$1,179.09
+31.7% upside to fair value
High Conviction
Grade A
High Quality
VS
Walmart Inc. · Consumer Defensive
$117.18
-39.6% upside to fair value
Grade C
High Quality
QuantHub Verdict
LLY has more upside to fair value
(+31.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
WMT |
| Current Price |
$1,179.09 |
$117.18 |
| Fair Value Estimate |
$1,552.32 |
$70.81 |
| Upside to Fair Value |
+31.7%
|
-39.6%
|
| Market Cap |
$1,110.4B |
$932.5B |
| Forward P/E |
—
|
41.1x
|
| EV / EBITDA |
34.3x
|
20.7x
|
| Price / Sales |
14.6x
|
1.3x
|
| Price / FCF |
77.7x
|
74.3x
|
| Revenue Growth YoY |
+55.5%
|
+7.3%
|
| Gross Margin |
83.5%
|
25.0%
|
| Operating Margin |
45.9%
|
4.2%
|
| Return on Equity |
101.3%
|
24.3%
|
| Dividend Yield |
0.55% |
0% |
| FCF Yield |
1.29%
|
1.35%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Eli Lilly is a global biopharma company whose exceptionally profitable cardiometabolic franchises, led by Mounjaro and Zepbound, are driving a high-quality growth phase: revenue rose 55.5% year over year and earnings rose 168.0% year over year in the most recent quarter, while gross, operating, and net margins were 83.5%, 45.9%, and 35.0%, respectively. Business quality is high because tirzepatid…
Walmart Inc. operates as a leading discount retailer with a strong competitive moat built on scale, cost leadership, and advanced logistics and technology infrastructure. The company benefits from a diversified revenue base with Walmart U.S. contributing 69%, International 18%, and Sam's Club 13%. Despite solid revenue growth of 7.3% and earnings growth of 25.9% in the most recent quarter, the st…
Accumulation Zones
| Metric |
LLY |
WMT |
| Zone Low |
$1,164.24 |
$53.11 |
| Zone High |
$1,319.47 |
$60.19 |
| In Buy Zone? |
Yes
|
No
|